Results 101 to 110 of about 178,708,228 (184)
Periodontology 2000, EarlyView.Abstract Objectives This review synthesizes evidence regarding the prevalence, epidemiological associations, and mechanistic pathways between osteoporosis, periodontal disease, and dental implant therapy. Materials and Methods A literature review was conducted to identify studies focused on: osteoporosis, periodontal disease, and dental implants ...
Samin Sirous +4 more
wiley +1 more source
, 2021 Medication related osteonecrosis of the jaw around previously osseointegrated implants: about 5 ...
Massaad, Jean +2 more
core
Treatment protocols for the medication-related osteonecrosis of the jaw [PDF]
, 2017 Povećanjem broja pacijenata koji primaju antiresoptivnu ili antiangiogenu terapiju, doktori dentalne medicine se sve češće susreću s medikamentoznom osteonekrozom čeljusti.
Ivković, Tena
core +1 more source
Early-Onset Bevacizumab-Associated Knee Osteonecrosis in a Young Adult With Astrocytoma
Annals of Internal Medicine: Clinical CasesWe describe a rare case of knee osteonecrosis in a 22-year-old man with astrocytoma and neurofibromatosis type 1 after short-term treatment with bevacizumab and corticosteroids. Magnetic resonance imaging (MRI) identified infarctions and osteonecrosis of
Chandra L. Kakarala +5 more
doaj +1 more source
Decoding host–microbial dynamics in peri‐implantitis: Ecosystem‐specific experimental models
Periodontology 2000, EarlyView.Abstract Background Peri‐implantitis is an inflammatory disease arising within a unique host–microbial–biomaterial ecosystem. Unlike periodontitis, peri‐implant tissues lack a periodontal ligament and epithelial junction integrity and interface with metal oxides on titanium surfaces.
Georgios A. Kotsakis +5 more
wiley +1 more source
Periodontology 2000, EarlyView.Abstract Background/Aim Antiresorptive therapy represents a cornerstone in the management of osteoporosis and cancer‐related bone disease through suppression of osteoclast‐mediated bone resorption. As implant therapy becomes more common in aging populations, clinicians increasingly encounter patients receiving these medications, thus making their ...
Emilio A. Cafferata +2 more
wiley +1 more source
Oral health and systemic health outcomes: A call for interdisciplinary action
Periodontology 2000, EarlyView.Abstract Objectives To make the case, from periodontology and dental public health, for interdisciplinary action on oral and systemic health, and to set out recommendations for practice, policy, education, and research. Materials and Methods A joint working group of the European Federation of Periodontology (EFP) and the European Association of Dental ...
Moritz Kebschull +29 more
wiley +1 more source
Bisphosphonates induced osteonecrosis of the jaw: a medical enigma?
, 2009 Bisphosphonates are used for the standard of care of patients with skeletal metastases and hypocalcemia of malignancy. Bisphosphonate-induced osteonecrosis (BION) is a serious complication.
Payne, Alan G.T. +2 more
core +1 more source
Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice [PDF]
, 2018 Bisphosphonate-related osteonecrosis of the jaw (BRONJ) worsens oral health-related quality of life. Most BRONJ occurs in multiple myeloma or metastatic breast cancer patients treated with bisphosphonate/chemotherapeutic combination therapies ...
Muneteru Sasaki +11 more
core +1 more source
Medication-related osteonecrosis of the jaw [PDF]
, 2015 In 2014, the nomenclature of bisphosphonate-related osteonecrosis of the jaw (BRONJ) was changed in medication-related osteonecrosis of the jaw (MRONJ) to include osteonecrosis of the jaw caused by non-bisphosphonates (BPs) drugs.
Pompa, Giorgio +5 more
core